This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Kadimastem Ltd., Yeda Research and Develpment & Co. Ltd. Active years: 2010-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2016
Title: Alon Levy: Innovator in Stem Cell Research
Introduction
Alon Levy is a prominent inventor based in Ramat-Hasharon, Israel. He has made significant contributions to the field of stem cell research, particularly in the generation of insulin-producing cells. With a total of 2 patents, his work has the potential to impact the treatment of diabetes and neurological disorders.
Latest Patents
Levy's latest patents include a method for generating insulin-producing islet cells from pluripotent stem cells. This innovative method involves culturing pluripotent stem cells in a differentiation medium to create endoderm cells. Following this, the endoderm cells are cultured in a medium containing growth factors and retinoic acid to generate further differentiated cells. Finally, these cells are matured using specific factors to produce islet cells. Another notable patent involves the use of IL6R/IL6 chimera for the treatment of neurological diseases, highlighting his versatility in addressing various medical challenges.
Career Highlights
Throughout his career, Alon Levy has worked with esteemed organizations such as Yeda Research and Development Company and Kadimastem Ltd. His research has been pivotal in advancing the understanding and application of stem cell technology.
Collaborations
Levy has collaborated with notable figures in the field, including Michel Revel and Judith Chebath. These partnerships have further enriched his research and contributed to the success of his innovations.
Conclusion
Alon Levy's contributions to stem cell research and his innovative patents position him as a key figure in the scientific community. His work continues to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile